Centene Co. (NYSE:CNC) Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC trimmed its stake in Centene Co. (NYSE:CNC - Free Report) by 98.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,848 shares of the company's stock after selling 310,898 shares during the period. International Assets Investment Management LLC's holdings in Centene were worth $233,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. GAMMA Investing LLC raised its holdings in shares of Centene by 35.6% in the fourth quarter. GAMMA Investing LLC now owns 3,914 shares of the company's stock worth $237,000 after buying an additional 1,028 shares during the period. Principal Financial Group Inc. increased its stake in Centene by 3.7% in the 3rd quarter. Principal Financial Group Inc. now owns 621,664 shares of the company's stock worth $46,799,000 after buying an additional 22,233 shares during the period. B. Riley Wealth Advisors Inc. boosted its position in Centene by 32.4% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 4,152 shares of the company's stock valued at $307,000 after buying an additional 1,016 shares during the period. Tidal Investments LLC increased its position in shares of Centene by 21.8% during the third quarter. Tidal Investments LLC now owns 42,117 shares of the company's stock worth $3,171,000 after acquiring an additional 7,549 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Centene in the third quarter valued at approximately $211,000. Institutional investors own 93.63% of the company's stock.

Analyst Ratings Changes

CNC has been the topic of a number of recent research reports. Sanford C. Bernstein dropped their price target on Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 30th. Barclays increased their target price on shares of Centene from $91.00 to $93.00 and gave the stock an "overweight" rating in a report on Friday, December 13th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $90.00 price target on shares of Centene in a research report on Wednesday, December 11th. Truist Financial cut their price objective on shares of Centene from $89.00 to $84.00 and set a "buy" rating on the stock in a report on Friday, December 13th. Finally, Robert W. Baird dropped their target price on Centene from $83.00 to $66.00 and set a "neutral" rating on the stock in a research report on Friday, October 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $80.92.

Centene Stock Down 0.4 %

Shares of CNC stock traded down $0.26 during trading hours on Tuesday, reaching $63.44. 2,911,131 shares of the company's stock were exchanged, compared to its average volume of 4,523,629. The stock has a market cap of $32.03 billion, a PE ratio of 11.01, a PEG ratio of 0.78 and a beta of 0.45. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The stock's fifty day moving average price is $60.06 and its two-hundred day moving average price is $67.41. Centene Co. has a 1 year low of $55.03 and a 1 year high of $81.42.

Insiders Place Their Bets

In related news, CEO Sarah London bought 4,117 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas Greco acquired 17,000 shares of the company's stock in a transaction dated Wednesday, December 18th. The shares were purchased at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the purchase, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 45,010 shares of company stock valued at $2,660,276. Insiders own 0.33% of the company's stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.